Literature DB >> 27473097

Adrenal cryptococcosis in an immunosuppressed patient showing intensely increased metabolic activity on 18F-FDG PET/CT.

Georgios Z Papadakis1, Steven M Holland2, Martha Quezado3, Nicholas J Patronas4.   

Abstract

Disseminated cryptococcosis most commonly occurs in immunosuppressed patients and can rarely affect the adrenal glands. We report on a patient with biopsy proven bilateral adrenal cryptococcosis resulting in primary adrenal insufficiency, which was evaluated with whole-body positron emission tomography/computed tomography scan using 18F-FDG. Both enlarged adrenal glands presented intensely increased 18F-FDG activity in the periphery, while central necrotic regions were photopenic. Although diagnosis was established by adrenal gland biopsy, 18F-FDG positron emission tomography/computed tomography scan can significantly contribute to the assessment of disease activity and monitoring of treatment response. Furthermore, fungal infections should always be considered when encountering hypermetabolic adrenal masses, especially in the setting of immunodeficient patients.

Entities:  

Keywords:  18F-FDG PET/CT; Adrenal cryptococcosis; Primary adrenal insufficiency

Mesh:

Substances:

Year:  2016        PMID: 27473097      PMCID: PMC5107323          DOI: 10.1007/s12020-016-1040-4

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  3 in total

Review 1.  Potential role of 18F-FDG PET/CT in patients with fungal infections.

Authors:  Punit Sharma; Anirban Mukherjee; Sellam Karunanithi; Chandrasekhar Bal; Rakesh Kumar
Journal:  AJR Am J Roentgenol       Date:  2014-07       Impact factor: 3.959

2.  Disseminated cryptococcosis causes adrenal insufficiency in an immunocompetent individual.

Authors:  Zui-Sheng Hung; Yu-Hsien Lai; Yung-Hsiang Hsu; Chih-Hsien Wang; Te-Chao Fang; Bang-Gee Hsu
Journal:  Intern Med       Date:  2010-06-01       Impact factor: 1.271

Review 3.  Cryptococcosis.

Authors:  Ricardo Negroni
Journal:  Clin Dermatol       Date:  2012 Nov-Dec       Impact factor: 3.541

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.